Design and baseline characteristics of a cohort study in Japanese patients with hypercholesterolemia: the Japan lipid intervention trial (J-LIT)

[1]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[2]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[3]  W. Kannel,et al.  Cigarette smoking and HDL cholesterol: the Framingham offspring study. , 1978, Atherosclerosis.

[4]  M. Marmot,et al.  Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan 1980-1989. , 1993, International journal of epidemiology.

[5]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[6]  A. Alberts,et al.  Discovery, biochemistry and biology of lovastatin. , 1988, The American journal of cardiology.

[7]  R. Collins,et al.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[8]  J. Patsch,et al.  Triglyceride-rich lipoproteins and atherosclerosis. , 1994, Atherosclerosis.

[9]  A. Folsom,et al.  Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. , 1989, International journal of epidemiology.

[10]  K. Kodama,et al.  Trend of coronary heart disease and its relationship to risk factors in a Japanese population: a 26-year follow-up, Hiroshima/Nagasaki study. , 1990, Japanese circulation journal.

[11]  P. Wilson,et al.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.

[12]  J. Huttunen,et al.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.

[13]  H. Iso,et al.  Trends for coronary heart disease and stroke and their risk factors in Japan. , 1989, Circulation.

[14]  H. Blackburn,et al.  The seven countries study: 2,289 deaths in 15 years. , 1984, Preventive medicine.

[15]  J. Neaton,et al.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.

[16]  D. Labarthe,et al.  Changes in cardiovascular disease risk factors in three Japanese national surveys 1971-1990. , 1996, Journal of epidemiology.

[17]  D. Grafnetter,et al.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. , 1978, British heart journal.

[18]  T. Omae,et al.  Changing Pattern of Cardiovascular Disease in the Japanese Population in Relation to Hypertension Control Programs , 1990, Journal of cardiovascular pharmacology.

[19]  M Halperin,et al.  Correlations of Plasma High‐density Lipoprotein Cholesterol Levels with Other Plasma Lipid and Lipoprotein Concentrations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[20]  S. Yusuf,et al.  Report of the Conference on Low Blood Cholesterol: Mortality Associations , 1992, Circulation.

[21]  D. Reed,et al.  Plasma Lipids and Lipoproteins in Elderly Japanese‐American Men , 1986, Journal of the American Geriatrics Society.

[22]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[23]  M. Karvonen,et al.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. , 1979, British heart journal.

[24]  H. Iso,et al.  Epidemiology of cerebrovascular disease: stroke epidemic in Japan. , 1996, Journal of epidemiology.

[25]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.